...
首页> 外文期刊>Journal of Medicinal Chemistry >Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor
【24h】

Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor

机译:一种有效和选择性的双重ATP和底物竞争性亚纳摩尔二齿c-Jun N末端激酶(JNK)抑制剂的设计和表征

获取原文
获取原文并翻译 | 示例

摘要

c-Jun N-terminal kinases (JNKs) represent valuable targets in the development of new therapies. Present on the surface of JNK is a binding pocket for substrates and the scaffolding protein JIP1 in close proximity to the ATP binding pocket. We propose that bidentate compounds linking the binding energies of weakly interacting ATP and substrate mimetics could result in potent and selective JNK inhibitors. We describe here a bidentate molecule, 19, designed against JNK. 19 inhibits JNK kinase activity (IC_(50) = 18 nM; K _i = 1.5 nM) and JNK/substrate association in a displacement assay (IC_(50) = 46 nM; K_i = 2 nM). Our data demonstrate that 19 targets for the ATP and substrate-binding sites on JNK concurrently. Finally, compound 19 successfully inhibits JNK in a variety of cell-based experiments, as well as in vivo where it is shown to protect against Jo-2 induced liver damage and improve glucose tolerance in diabetic mice.
机译:c-Jun N末端激酶(JNK)代表了新疗法开发中的重要靶标。 JNK的表面上有一个底物的结合袋,而支架蛋白JIP1紧靠ATP结合袋。我们建议,将弱相互作用的ATP和底物模拟物的结合能联系起来的双齿化合物可能会产生有效的选择性JNK抑制剂。我们在这里描述针对JNK设计的19位双齿分子。 19在置换试验中抑制JNK激酶活性(IC_(50)= 18 nM; K _i = 1.5 nM)和JNK /底物缔合(IC_(50)= 46 nM; K_i = 2 nM)。我们的数据表明,JNK上的ATP和底物结合位点同时存在19个靶标。最后,化合物19在各种基于细胞的实验中以及在体内均成功抑制JNK,在体内它被证明可以抵抗Jo-2诱导的肝损伤并改善糖尿病小鼠的葡萄糖耐量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号